Spero Therapeutics Inc. (SPRO)
Market Closed
16 Oct, 08:00 PM
$
1. 10
-0.03
-2.6549%
$
64.06M Market Cap
3.69 P/E Ratio
- Div Yield
361,300 Volume
-0.52 Eps
$ 1.13
Previous Close Want to track SPRO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Spero Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Madelyn D. Purcell Pfizer Inc | 2.36M | $2.43M | $2.62M | $188,988.31 | 7.77% |
 Point72 Asset Management LP Point72 Asset Management LP | 104,377 | $237,994.05 | $117,946.01 | -$120,048.04 | -50.44% |
 Christopher C. Powers Farther Finance Advisors, LLC | 10 | $23 | $11.2 | -$11.8 | -51.3% |
| MA Marie-Andree Alain Federation des caisses Desjardins du Quebec | 91,900 | $202,180 | $103,847 | -$98,333 | -48.64% |
 Carmen McClennon WR Wealth Planners, LLC | 2,600 | $4,472 | $2,925 | -$1,547 | -34.59% |
 Tory Parke Three Seasons Wealth LLC | 30,000 | $42,150 | $34,800 | -$7,350 | -17.44% |
| EG Ethan Gilbert Rialto Wealth Management LLC | 172 | $381 | $194.36 | -$186.64 | -48.99% |
2026 © Marketlog. All Rights Reserved.
